The Nanotechnology Knowledge Transfer Network (NanoKTN) will host a roundtable discussion on the impact of nanotechnology on medical device development on 24 January 2013 at Brunel University in London. Produced in association with eSTI2 (of the UKCRC translational infection research initiative consortium), the half-day event will include a presentation of three case studies followed by what is promised to be a stimulating discussion on the role of nanotechnology in facilitating medical device breakthroughs. Confirmed speakers hail from eSTI2 , Brunel University, Imperial College London, Cambridge Consultants and Vivacta. A networking drinks reception will end the day. This is the inaugural event of the Nanotechnology in Medical Devices (NiMeD) focus group, which was launched in early 2012 by NanoKTN.
“We hope that the first NiMeD event will provide an excellent opportunity for delegates to hear new ideas, network with peers and meet technology providers,” said Dr Felicity Sartain, Theme Manager – Healthcare & Life Sciences, NanoKTN, in a press release. “The UK is a significant player in the medical device industry and we have already seen the huge impact that nanotechnology is delivering. With the growing use of miniaturisation technology from the semiconductor manufacturing world, we are now seeing truly life-changing nanotechnology innovations for the aging population.”
For additional information about the event and to register, visit www.nanoktn.com.Norbert Sparrow